BlackRock Fund Advisors - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 43 filers reported holding NEOS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$2,612,000
-35.3%
446,443
-27.3%
0.00%
-100.0%
Q3 2016$4,038,000
-23.1%
613,698
+8.4%
0.00%0.0%
Q2 2016$5,254,000
+36.4%
566,112
+58.5%
0.00%0.0%
Q1 2016$3,853,000
-20.0%
357,058
+6.2%
0.00%0.0%
Q4 2015$4,815,000
+58.4%
336,227
+132.3%
0.00%0.0%
Q3 2015$3,040,000144,7140.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders